- Home
- PAGP vs PLXS Comparison
PAGP vs PLXS Comparison
Compare PAGP & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PAGP | PLXS |
|---|---|---|
| Founded | 2013 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Electrical Products |
| Sector | Energy | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 4.0B |
| IPO Year | 2013 | 1986 |
Fundamental Metrics
Financial Performance| Metric | PAGP | PLXS |
|---|---|---|
| Price | $18.78 | $154.02 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $20.17 | ★ $160.00 |
| AVG Volume (30 Days) | ★ 1.4M | 210.1K |
| Earning Date | 02-06-2026 | 01-21-2026 |
| Dividend Yield | ★ 8.05% | N/A |
| EPS Growth | 11.94 | ★ 56.11 |
| EPS | 0.95 | ★ 6.26 |
| Revenue | ★ $46,917,000,000.00 | $4,032,966,000.00 |
| Revenue This Year | N/A | $10.99 |
| Revenue Next Year | $7.33 | $7.02 |
| P/E Ratio | ★ $19.97 | $24.60 |
| Revenue Growth | N/A | ★ 1.82 |
| 52 Week Low | $16.61 | $103.43 |
| 52 Week High | $22.31 | $172.89 |
Technical Indicators
Market Signals| Indicator | PAGP | PLXS |
|---|---|---|
| Relative Strength Index (RSI) | 55.31 | 55.18 |
| Support Level | $18.53 | $151.94 |
| Resistance Level | $19.01 | $156.41 |
| Average True Range (ATR) | 0.25 | 5.19 |
| MACD | -0.03 | -0.52 |
| Stochastic Oscillator | 44.70 | 34.39 |
Price Performance
Historical ComparisonAbout PAGP Plains GP Holdings L.P. Units representing Limited Partner Interests
Plains GP Holdings LP provides transportation, storage, processing, fractionation, and marketing services for crude oil, refined products, natural gas liquids, liquefied petroleum gas, and related products. The group manages its operations through two operating segments: Crude Oil and NGL.
About PLXS Plexus Corp.
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.